クリックしてご覧ください

 

1. Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M.Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease dogs
and assessing disease severity. JAVMA. 2008; 232(10): 1496.1503.
2. Paige CF, Abbott JA, Pyle RL, Elvinger F. Prevalence of cardiomyopathy in apparently healthy cats. JAVMA 2009; 234(11): 1398
3. Connolly DJ, Soares Magalhaes RJ, Syme HM, Boswood A, Fuentes VL, Chu L, Metcalf M. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med. 2008; 22(3): 96.105
4. Fox PR, Oyama MA, MacDonald K, Reynolds CA, Assessment of NTproBNP concentration in asymptomatic cats with cardiomyopathy[ACVIM Abstract 191]. J Vet Intern Med. 2009; 22(3): 759.
5. Fox PR, J.E. Rush, C.A. Reynolds, et.al. Multicenter Evaluation of Plasma N-Terminal Probrain Natriuretic Peptide(NT-proBNP) as a Biochemical Screening Test for Asymptomatic (occult) Cardiomyopathy in Cats. J Vet Intern Med. 2011; 25: 1010-1016